Page last updated: 2024-08-22

trimetazidine and Cardiovascular Diseases

trimetazidine has been researched along with Cardiovascular Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Lu, Y; Ni, H; Shi, H; Sun, Y; Wang, F1
Chen, Y; Dalal, JJ; Danchin, N; Etriby, E; Ferrari, R; Gowdak, LH; Lopaschuk, G; Lopatin, Y; Marzilli, M; Milicic, D; Parkhomenko, A; Pinto, F; Ponikowski, P; Rosano, GMC; Seferovic, P; Vinereanu, D1
Banach, M; Chrusciel, P; Rysz, J1

Reviews

2 review(s) available for trimetazidine and Cardiovascular Diseases

ArticleYear
Trimetazidine in cardiovascular medicine.
    International journal of cardiology, 2019, 10-15, Volume: 293

    Topics: Cardiology; Cardiotonic Agents; Cardiovascular Diseases; Energy Metabolism; Humans; Trimetazidine; Vasodilator Agents

2019
Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.
    Drugs, 2014, Volume: 74, Issue:9

    Topics: Cardiovascular Agents; Cardiovascular Diseases; Heart Failure; Humans; Peripheral Arterial Disease; Trimetazidine

2014

Other Studies

1 other study(ies) available for trimetazidine and Cardiovascular Diseases

ArticleYear
Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine.
    BioMed research international, 2022, Volume: 2022

    Topics: Aged; Cardiovascular Diseases; China; Coronary Disease; Glucose; Heart Failure; Humans; Metoprolol; Middle Aged; Trimetazidine

2022